Tetra Bio Pharma Inc
F:JAM1

Watchlist Manager
Tetra Bio Pharma Inc Logo
Tetra Bio Pharma Inc
F:JAM1
Watchlist
Price: 0.076 EUR -5% Market Closed
Market Cap: 104.1m EUR

Relative Value

JAM1 price has not been updated for more than 6 years. This may indicate that the stock has been delisted.
JAM1 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of JAM1.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JAM1 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.3
Industry
21.6
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-1.3
Industry
16.5
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.1
Industry
22.5
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-1.8
Industry
2.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
13
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
16.6
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.4
Industry
15.8
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.4
Industry
19.1
vs History
vs Industry
Median 3Y
4.6
Median 5Y
4.6
Industry
1.9

Multiples Across Competitors

JAM1 Competitors Multiples
Tetra Bio Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Tetra Bio Pharma Inc
F:JAM1
10.6m EUR 0 -0.3 -0.9 -0.9
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 16.4 52.8 35.5 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 5.5 20.3 16.6 21.5
CH
Roche Holding AG
SIX:ROG
252.3B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 4.8 29.7 108 158
CH
Novartis AG
SIX:NOVN
202.4B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 2.3 15 7.6 10.4
P/S Multiple
Revenue Growth P/S to Growth
CA
Tetra Bio Pharma Inc
F:JAM1
Average P/S: 71.4
Not Available
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
16.4
26%
0.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
9%
64.3
US
Johnson & Johnson
NYSE:JNJ
5.5
6%
0.9
CH
Roche Holding AG
SIX:ROG
4.1
3%
1.4
UK
AstraZeneca PLC
LSE:AZN
4.8
8%
0.6
CH
Novartis AG
SIX:NOVN
4.5
5%
0.9
US
Merck & Co Inc
NYSE:MRK
3.9
4%
1
DK
Novo Nordisk A/S
CSE:NOVO B
4.5
6%
0.8
IE
E
Endo International PLC
LSE:0Y5F
90.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
2.3
-2%
N/A
P/E Multiple
Earnings Growth PEG
CA
Tetra Bio Pharma Inc
F:JAM1
Average P/E: 23.6
Negative Multiple: -0.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.8
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Tetra Bio Pharma Inc
F:JAM1
Average EV/EBITDA: 438.7
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Tetra Bio Pharma Inc
F:JAM1
Average EV/EBIT: 1 881.1
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3